Atlas Trials

A Study of AS1411 Combined With Cytarabine in the Treatment of Patients With Primary Refractory or Relapsed Acute Myeloid Leukemia

Clinical trial NCT01034410 · TERMINATED

Trial details

NCT number
NCT01034410
Sponsor
Antisoma Research
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Myeloid Leukemia
Start date
2010-01-01
Primary completion
2011-01-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.